During the past decade, Hope Cancer Care of Nevada-Pahrump conducted 99 clinical trials. In the 10-year time frame, 99 clinical trials started and 21 clinical trials were completed, i.e. on average, 21.2% percent of trials that started reached the finish line to date. In the past 5 years, 40 clinical trials started and 21 clinical trials were completed. i.e. 52.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hope Cancer Care of Nevada-Pahrump" #1 sponsor was "National Cancer Institute (NCI)" with 50 trials, followed by "Alliance for Clinical Trials in Oncology" with 20 trials sponsored, "SWOG Cancer Research Network" with 17 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 12 trials sponsored and "Children's Oncology Group" with 12 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hope Cancer Care of Nevada-Pahrump" #1 collaborator was "National Cancer Institute (NCI)" with 54 trials as a collaborator, "Canadian Cancer Trials Group" with 7 trials as a collaborator, "NRG Oncology" with 4 trials as a collaborator, "Genentech, Inc." with 2 trials as a collaborator and "Bayer" with 1 trials as a collaborator. Other collaborators include 2 different institutions and companies that were collaborators in the rest 12 trials.

According to Clinical.Site data, the most researched conditions in "Hope Cancer Care of Nevada-Pahrump" are "Invasive Breast Carcinoma" (6 trials), "Stage IV Lung Cancer AJCC v8" (6 trials), "Recurrent Lung Non-Small Cell Carcinoma" (5 trials), "Recurrent Ovarian Carcinoma" (4 trials) and "Stage IV Renal Cell Cancer AJCC v8" (4 trials). Many other conditions were trialed in "Hope Cancer Care of Nevada-Pahrump" in a lesser frequency.

Most popular intervention types in "Hope Cancer Care of Nevada-Pahrump" are "Drug" (84 trials), "Other" (60 trials), "Biological" (46 trials), "Procedure" (36 trials) and "Radiation" (10 trials). Other intervention types were less common.

The name of intervention was led by "Quality-of-Life Assessment" (27 trials), "Computed Tomography" (23 trials), "Biospecimen Collection" (22 trials), "Laboratory Biomarker Analysis" (19 trials) and "Nivolumab" (19 trials). Other intervention names were less common.

The vast majority of trials in "Hope Cancer Care of Nevada-Pahrump" are 94 trials for "All" genders, 9 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Hope Cancer Care of Nevada-Pahrump". undefined are not yet recruiting, 39 are recruiting, 52 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Hope Cancer Care of Nevada-Pahrump, 4 suspended trials, and 6 terminated clinical trials to date.

Out of the total trials that were conducted in Hope Cancer Care of Nevada-Pahrump, 2 "Phase 1" clinical trials were conducted, 56 "Phase 2" clinical trials and 48 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".